PUNE, India, Dec. 12, 2019 /PRNewswire/ -- In recent years, telehealth for women's reproductive and sexual health market has been witnessing a significant growth. The market holds potential to penetrate significantly into areas such as contraceptives, STD testing and treatment, and abortion care. Areas which exhibit highest demand for telehealth services in women's reproductive and sexual health market are birth control, Postpartum Depression and Urinary Tract Infection (UTI). In the U.S. and Europe, adoption of telecontraception is on a rise and the industry is witnessing more number of participants in the virtual healthcare space catering to women. In the present scenario, majority of demand is concentrated into developed economies owing to higher adoption of technology and awareness among users towards such services. The North America region accounted for around 50% of the telehealth for women's reproductive and sexual health market in 2018 with the U.S. being the primary market. However, the foremost barrier in telehealth is lack of reimbursement policy and service providers tend to be reimbursed at lower level as compared to the in-person service providers.
Telehealth is a cost efficient alternative for conventional healthcare services. With rising adoption of and dependence on smartphones, virtual healthcare services have been gaining traction. Women's reproductive and sexual health is a business segment which more number of telehealth providers have been targeting with working women as their major target customers.
The detailed research study provides qualitative and quantitative analysis of telehealth for women's reproductive and sexual health market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue across regions and further across all the major countries. The supply side analysis covers the major market players and their regional and global presence and strategies. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
In terms of revenue, global telehealth for women's reproductive and sexual health market is expected to reach US$ 215.70 million by 2027, as there is an increasing demand for telehealth abortion services across developed countries.
Birth Control, Urinary Tract Infection (UTI), and Postpartum Depression together accounted for more than 60% of the market in 2018.
In terms of offering, the consulting service segment is expected to reach US$ 138.82 million by 2027, growing at an estimated CAGR of 16.3% over the forecast period
Asia Pacific telehealth for women's reproductive and sexual health market is projected to witness the highest CAGR of 18.0% over the forecast period.
Some of the players operating in the telehealth for women's reproductive and sexual health market are American Well, HeyDoctor, LLC, ICEBREAKER HEALTH INC. (Lemonaid), Maven Clinic Co., NURX Inc., Pandia Health, Inc., PILL CLUB amongst others.
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization.
From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.